He says he read most of it. I thought the book included the strong argument that it would be really neat to have long-term safety and efficacy data so that we can have some real experience with these antidepressants. Considering that large numbers of users of these drugs take them for more than a year, let's not get too huffy and puffy about people questioning their safety, particularly over the longer term. But in the end, he raises important questions that will become increasingly difficult for Lilly and its doctor pals to duck. Perhaps the federal government needs to do long-term studies on the impacts of these drugs as the pharmaceutical companies have little incentive at this point to do it because the drugs have been on the market for several years.
Someone has to care about the long-term effects.
In his weekly column, published Wednesdays, he looks at medical trouble spots, heralds innovative achievements and analyzes health trends that may greatly influence our lives. His latest book is The Virus Within. For the rest of the latest health news, click here . Click here for Terms of Use and Privacy Policy and Internet Safety Information applicable to this site.